Secondary acute monocytic leukemia with a translocation t(8;16)(p11;p13): Case report and review of the literature

Leukemia and Lymphoma

Volumn 45, Issue 3, 2004, Pages 621-625

  Tasaka, Taizo ^a,b   Matsuhashi, Yoshiko ^a,b   Uehara, Eisuke ^a,b   Tamura, Takahiro ^a   Kakazu, Naoki ^c   Abe, Tatsuo ^c   Nagai, Masami ^b  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Carboplatin; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; HISTONE ACETYLTRANSFERASE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; NITROSOUREA; PACLITAXEL; PROCARBAZINE; VINCRISTINE;

ACUTE MONOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; AGED; ARTICLE; BLAST CELL; BREAST CANCER; BREAST TUMOR; CANCER CLASSIFICATION; CASE REPORT; CHIMERA; CHROMOSOME 16P; CHROMOSOME 8P; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 8; ERYTHROPHAGOCYTOSIS; FEMALE; GENE FUSION; GENE LOCATION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HODGKIN DISEASE; HUMAN; KARYOTYPING; LEUKEMOGENESIS; LYMPHOMA; MERKEL CELL TUMOR; METASTASIS; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PACLITAXEL; TRANSLOCATION, GENETIC;

EID: 1042292008     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190310001593058     Document Type: Article

References (26)

1. Predersen-Bjergaard, J., Predersen, M., Roulston, D. and Philip, P. (1995) "Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia." Blood, 86, 3542-3552.
2. Devereux, S. (1991) "Therapy associated leukemia", Blood Reviews, 5, 138-145.
3. Quesnel, B., Kantarjian, H., Bjergaard, J.P., Brault, P., Estey, E., Lai, J.L., et al. "Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature." Jounal of Clinical Oncolology, 11, 2370-2379.
4. Predersen-Bjergaard, J., Sigsgaard, T.C., Nielsen, D., Gjedde, S.B., Philip, P., Hansen, M., et al. (1992) "Acute monocytic or myelocytic leukemia with balanced chromosome translocation to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer." Journal of Clinical Oncolology, 10, 1444-1451.
5. Mitelman, F. and Heim, S. (1992) "Quantitative acute leukemia cytogenetics." Genes Chromosomes and Cancer, 5, 57-66.
6. Velloso, E.R., Mecucci, C., Michaux, L., Van Orshoven, A., Stul, M., Boogaerts, M., et al. (1996) "Translocation t(8;16 (p11;p13) in acute non-lymphocytic leukemia: report on two new cases and review of the literature." Leukemia Lymphoma, 21, 137-142.
7. Schouten, T.J., Hustinx, T.W., Scheres, J.M., Holland, R. and de Vaan, G.A. (1983) "Malignant histiocytosis: clinical and cytogenetic studies in newborn and a child." Cancer, 52, 1229-1236.
8. Heim, S., Avanzi, G.C., Billstrom, R., Kristoffersson, U., Mandahl, N., Bekassy, A.N., et al. (1987) "A new specific chromosomal rearrangement, t(8;16)(p11;p13) in acute monocytic leukemia." British Journal of Haematology, 66, 323-326.
9. Stark, B., Resnitzky, P., Jeison, M., Luria, D., Blau, O., Avigad, S., et al. (1995) "A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8;16)(p11;p13)-case report and review of the literature." Leukemia Research, 19, 367-379.
10. Lai, J.L., Zandecki, M., Jouet, J.P., Savary, J.B., Lambiliotte, A., Bauters, F., et al. (1987) "Three cases of translocation (8;16)(p11;p13) observed in acute myelomonocytic leukemia: a new specic subgroup?" Cancer Genetic Cytogenetics, 27, 101-109.
11. Brookwell, R. and Hunt, F.A. (1988) "Translocation (8;16) in acute myelomonocytic leukemia." Cancer Genetic Cytogenetics, 32, 297-298.
12. Barbata, G., Carbone, P., Mirto, S., Santoro, A., Giglio, M.C. and Granata, G. (1989) "Translocation t(8;16)(p11;p13) in acute nonlymphoblastic leukemia (M4) possibly secondary to Hodgkin's disease." Cancer Genetic Cytogenetics, 37, 127-131.
13. Demuynck, H., Verhoef, G.E., Zachee, P., Vandenberghe, P., Van Orshoven, A., Paridaens, R., et al. (1995) "Therapy-related acute myeloid leukemia with t(8;16)(p11;p13) following anthracycline-based therapy for nonmetastatic osteosarcoma." Cancer Genetic Cytogenetics, 82, 103-105.
14. Savasan, S., Mohamed, A.N., Lucas, D.R., Dugan, M.C., Ryan, J.R. and Ravindranath, Y. (1996) "Acute myeloid leukemia with t(8;16)(p11;p13) in a child after intrauterine X-ray exposure." British Journal of Haematology, 94, 702-704.
15. Dissing, M., Le Beau, M.M. and Predersen-Bjergaard, J. (1998) "Inversion of chromosome 16 and uncommon rearrangements of CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?" Jounal of Clinical Oncolology, 16, 1890-1896.
16. Seymour, J.F., Juneja, S.K., Campbell, L.J., Ellims, P.H., Estey, E.H. and Prince, H.M. (1999) "Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role intesified ara-C therapy." Leukemia, 13, 1735-1740.
17. Panagopoulos, I., Isaksson, M., Lindvall, C., Bjorkholm, M., Ahlgren, T., Fioretos, T., et al. (2000) "RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13)." Genes Chromosomes and Cancer, 28, 415-428.
18. Golub, T.R. (1999) The genetics of AML: An update. In: Hematology, edited G.P. Schechter, S. Hoffman, S.L. Chrier. pp.102-111. Washington, DC: The American Society of Hematology.
19. Borrow, J., Stanton, V.P. Jr, Andresen, J.M., Becher, R., Behm, F.G., Chaganti, R.S., et al. (1996) "The translocation t(8;16)(p11;p13) of acute myeloid leukemia fuses a putative acetyltransferase to the CREB-binding protein." Nature Genetics, 14, 33-41.
20. Chaffanet, M., Gressin, L., Preudhomme, C., Soenen-Cornu, V., Birnbaum, D. and Pebusque, M.J. (2000) "MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)." Genes Chromosomes and Cancer, 28, 138-144.
21. Giles, R.H., Dauwerse, J.G., Higgins, C., Petrij, F., Wessels, J.W., Beverstock, G.C., et al. (1997) "Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)." Leukemia, 11, 2087-2096.
22. Michallet, A.S., Lai, J.L., Bauters, F., Fenaux P. and Quesnel, B. (1998) "A new case of therapy-related acute myeloid leukemia with t(8;16)(p11;q13)."British Journal of Haematology, 100, 801-802.
23. Kaldor, J.M., Day, N.E., Pettersson, F., Clarke, E.A., Pedersen, D., Mehnert, W., et al. (1990) "Leukemia following Hodgkin's disease." New England Journal of Medicine, 322, 7-13.
24. Travis, L.B., Holowaty, E.J., Bergfeldt, K., Lynch, C.F., Kohler, B.A., Wiklund, T., et al. (1999) "Risk of leukemia after platinum-based chemotherapy for ovarian cancer." New England Journal of Medicine, 340, 351-357.
25. Donehower, R.C., Abeloff, M.D. and Perry, M.C. (1995) Chemotherapy. In: Clinical Oncology, edited by M.D. Abeloff, J.O. Armitage, A.S. Lichter, J.E. Neiderhuber. pp. 201-218. New York: Churchill Livingstone.
26. Philpott, N.J., Elebute, M.O., Powles, R., Treleaven, J.G., Gore, M., Dainton, M.G., et al. (1996) "Platinum agents and secondary myeloid leukaemia: two cases treated only with platinum-based drugs." British Journal of Haematology, 93, 884-887.